» Articles » PMID: 10525974

Long-term Recovery and Fellow Eye Deterioration After Optic Neuritis, Determined by Serial Visual Evoked Potentials

Overview
Journal J Neurol
Specialty Neurology
Date 1999 Oct 20
PMID 10525974
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Twelve optic neuritis patients (part of a larger group in whom the effects of intravenous methylprednisolone treatment were previously reported), were followed-up 3 years from the onset of symptoms with visual evoked potentials (VEPs), contrast sensitivity and visual field examination. Findings from the previously "unaffected" eyes, none of which had had symptomatic optic neuritis, were also assessed. Between 6 months and 3 years after the onset of symptoms the VEPs of the affected eyes showed a significant shortening of mean latency (whole field, 131-123 ms; central field, 136-125 ms). Conversely, the responses of the previously unaffected eyes showed a contemporaneous latency prolongation (significant for the whole field, 110-113 ms) which exceeded the expected effect of aging. Contrast sensitivity tests showed no significant change in the affected eyes but a mild deterioration in the unaffected eyes, while the visual fields showed no overall pattern of improvement or deterioration. If the strong tendency for VEP latencies to shorten is due to ongoing remyelination, the lack of significant improvement in visual function may be because the visual deficit at 6 months is due to irreversible axonal loss rather than demyelination. The absence of functional deterioration in the affected eye, while VEPs and contrast sensitivity deteriorated in the unaffected eye, suggests that long-term remyelination may for a while counteract the effects of insidious demyelination and axonal degeneration which affect the visual pathway during clinical remission.

Citing Articles

Different visual evoked potentials in neuromyelitis optica spectrum disorder-related optic neuritis and idiopathic demyelinating optic neuritis: a prospective longitudinal analysis.

Zheng C, Wang L, Xu X, Zhou M, Liu K, Zhang Y BMC Ophthalmol. 2022; 22(1):376.

PMID: 36131262 PMC: 9490973. DOI: 10.1186/s12886-022-02595-5.


Clinical electrophysiology of the optic nerve and retinal ganglion cells.

Marmoy O, Viswanathan S Eye (Lond). 2021; 35(9):2386-2405.

PMID: 34117382 PMC: 8377055. DOI: 10.1038/s41433-021-01614-x.


Fingolimod after a first unilateral episode of acute optic neuritis (MOVING) - preliminary results from a randomized, rater-blind, active-controlled, phase 2 trial.

Albert C, Mikolajczak J, Liekfeld A, Piper S, Scheel M, Zimmermann H BMC Neurol. 2020; 20(1):75.

PMID: 32126977 PMC: 7052969. DOI: 10.1186/s12883-020-01645-z.


Promoting remyelination in multiple sclerosis.

Cunniffe N, Coles A J Neurol. 2019; 268(1):30-44.

PMID: 31190170 PMC: 7815564. DOI: 10.1007/s00415-019-09421-x.


Multifocal visual evoked potentials and contrast sensitivity correlate with ganglion cell-inner plexiform layer thickness in multiple sclerosis.

Narayanan D, Cheng H, Tang R, Frishman L Clin Neurophysiol. 2018; 130(1):180-188.

PMID: 30473445 PMC: 6309727. DOI: 10.1016/j.clinph.2018.10.007.